Objective: To explore stroke survivors' experiences of undertaking exercise in the context of an exercise referral scheme for people with chronic stroke.
Design: A qualitative design, using semi-structured interviews within a constructivist framework to explore the experiences of individual participants. Verbatim transcripts were thematically analysed.
Background And Purpose: Botulinum toxin is increasingly used to treat upper limb spasticity due to stroke, but its impact on arm function is unclear. We evaluated botulinum toxin for upper limb spasticity and function poststroke.
Methods: Three hundred thirty-three patients with stroke with upper limb spasticity and reduced arm function participated in a multicenter randomized controlled trial.
Introduction: Spasticity is a significant cause of disability in people with an upper motor neurone lesion, but there is a paucity of appropriate outcome measures to evaluate this phenomenon. The aim was to test the construct validity of a clinically relevant, non-invasive measure of spasticity.
Methods: A cross-section study design in which participants with elbow flexor spasticity and capable of providing written informed consent were recruited.
Objective: To quantify the clinical efficacy of botulinum toxin type A in treating elbow flexor spasticity in a unilateral stroke population.
Location: A spasticity clinic at a regional neurological rehabilitation centre.
Study Design: A convenience sample longitudinal study.